Royal London Asset Management Ltd. Boosts Holdings in CVS Health Co. (NYSE:CVS)

Royal London Asset Management Ltd. grew its position in shares of CVS Health Co. (NYSE:CVSFree Report) by 3.2% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 493,110 shares of the pharmacy operator’s stock after purchasing an additional 15,061 shares during the period. Royal London Asset Management Ltd.’s holdings in CVS Health were worth $34,436,000 at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of CVS. Live Oak Investment Partners bought a new stake in shares of CVS Health in the fourth quarter worth $25,000. Cornerstone Planning Group LLC increased its stake in CVS Health by 111.5% during the third quarter. Cornerstone Planning Group LLC now owns 461 shares of the pharmacy operator’s stock valued at $32,000 after purchasing an additional 243 shares during the last quarter. PCA Investment Advisory Services Inc. bought a new stake in CVS Health during the second quarter valued at $37,000. True Wealth Design LLC bought a new stake in CVS Health during the fourth quarter valued at $48,000. Finally, Godsey & Gibb Inc. increased its stake in CVS Health by 153.5% during the third quarter. Godsey & Gibb Inc. now owns 758 shares of the pharmacy operator’s stock valued at $53,000 after purchasing an additional 459 shares during the last quarter. 75.99% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other CVS Health news, EVP Prem S. Shah sold 29,473 shares of the company’s stock in a transaction dated Friday, February 16th. The shares were sold at an average price of $76.95, for a total transaction of $2,267,947.35. Following the sale, the executive vice president now directly owns 39,765 shares of the company’s stock, valued at $3,059,916.75. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Insiders own 0.25% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have weighed in on CVS shares. StockNews.com lowered shares of CVS Health from a “buy” rating to a “hold” rating in a research note on Thursday, February 15th. HSBC started coverage on shares of CVS Health in a report on Friday, December 22nd. They issued a “buy” rating and a $94.00 price objective for the company. SVB Leerink started coverage on shares of CVS Health in a research note on Monday, February 26th. They set an “outperform” rating and a $88.00 price objective on the stock. TD Cowen decreased their price target on shares of CVS Health from $102.00 to $99.00 and set an “outperform” rating on the stock in a research report on Monday, December 11th. Finally, Barclays started coverage on shares of CVS Health in a research note on Wednesday. They issued an “equal weight” rating and a $78.00 price objective for the company. Four analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $89.58.

View Our Latest Stock Analysis on CVS Health

CVS Health Stock Down 0.1 %

NYSE:CVS opened at $74.27 on Friday. The firm’s 50 day simple moving average is $76.14 and its 200 day simple moving average is $72.33. The company has a debt-to-equity ratio of 0.77, a current ratio of 0.86 and a quick ratio of 0.63. CVS Health Co. has a one year low of $64.41 and a one year high of $83.25. The company has a market cap of $93.47 billion, a PE ratio of 11.50, a P/E/G ratio of 0.98 and a beta of 0.51.

CVS Health (NYSE:CVSGet Free Report) last released its quarterly earnings data on Wednesday, February 7th. The pharmacy operator reported $2.12 earnings per share for the quarter, beating the consensus estimate of $2.01 by $0.11. The company had revenue of $93.81 billion during the quarter, compared to analyst estimates of $90.58 billion. CVS Health had a net margin of 2.33% and a return on equity of 15.25%. CVS Health’s revenue for the quarter was up 11.9% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.99 EPS. On average, research analysts anticipate that CVS Health Co. will post 8.33 earnings per share for the current year.

CVS Health Profile

(Free Report)

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

See Also

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.